As part of their growth strategy, private biotech and pharmaceutical companies often seek to raise capital through initial public offerings (IPOs). In addition to raising capital, an IPO can give a life sciences company a...more
More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a 69 percent jump over the year...more
2/8/2019
/ Accounting Standards ,
Capital Formation ,
Capital Markets ,
Disclosure Requirements ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Internal Controls ,
Investment Banks ,
Life Sciences ,
Popular ,
Regulatory Standards ,
Reporting Requirements ,
Sarbanes-Oxley ,
Startups ,
Stock Exchange ,
Transparency